JOSEPH ROSE: Open Payments
NPI 1336901594 · GRENADA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 55 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $326 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $253 |
| Dendreon Pharmaceuticals LLC | 6 | $199 |
| Endo USA, Inc. | 8 | $139 |
| Janssen Biotech, Inc. | 5 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| PFIZER INC. | 4 | $86 |
| Merck Sharp & Dohme LLC | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Myriad Genetic Laboratories, Inc. | 2 | $44 |
| Antares Pharma, Inc. | 2 | $40 |
Products named: PROVENGE, ORGOVYX, XIAFLEX, ERLEADA, Nubeqa, GEMTESA, LYNPARZA, XTANDI.
Industry payments across MS — which companies pay providers there.
